Search

Your search keyword '"Lakey, David"' showing total 241 results

Search Constraints

Start Over You searched for: Author "Lakey, David" Remove constraint Author: "Lakey, David"
241 results on '"Lakey, David"'

Search Results

1. Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescents

3. A Participatory, State-Community-Academic Model to Improve Pregnancy Outcomes in Texas: The Healthy Families Initiative

4. Health Burden and Service Utilization in Texas Medicaid Deliveries from the Prenatal Period to 1 Year Postpartum

5. Assessing Knowledge, Practices, and Barriers to PrEP and nPEP Prescription Among Texas Healthcare Providers.

6. Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample

7. Factors associated with elevated SARS-CoV-2 immune response in children and adolescents.

8. Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents

10. Building a Health Communication Brand for University of Texas System Tobacco Control

12. Incidence of SARS-CoV-2 breakthrough infections after vaccination in adults: A population-based survey through March 1, 2023

13. Immediate Postpartum Long-Acting Reversible Contraception Programs in Texas Hospitals Following Changes to Medicaid Reimbursement Policy

14. Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescents

17. SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents

18. Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants

25. Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region

29. Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents

30. Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey

31. RE: Incidence of SARS-CoV-2 Breakthrough Infections After Vaccination in Adults: A Population-Based Survey Through 1 March 2023.

33. Impact of the SARS-CoV-2 Delta Variant Versus Pre-Delta Variants In Non-Hospitalized Children

34. Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey

35. Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents

36. Active Tracing and Monitoring of Contacts Associated With the First Cluster of Ebola in the United States

40. Estimation of Total Immunity to SARS-CoV-2 in Texas

41. Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results from Phase I of the Texas Coronavirus Antibody REsponse Survey (TX CARES)

43. sj-pdf-1-jpc-10.1177_21501327211017784 – Supplemental material for Experiences and Perspectives on Adopting New Practices for Social Needs-targeted Care in Safety-net Settings: A Qualitative Case Series Study

44. Estimated Prevalence of SARS-CoV-2 Antibodies in the Texas Pediatric Population, 2021

Catalog

Books, media, physical & digital resources